Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-11 | 89bio, Inc. | Shah Rajeev M.
(Director) |
X | Common Stock | A | 1408450 | $5.33 - $5.33 | $7,499,996 |
| 2024-03-04 | 89bio, Inc. | Shah Rajeev M.
(Director) |
P | Common Stock | A | 1350000 | $15.35 - $15.35 | $20,722,500 |
| 2024-02-26 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
S | Common Stock | D | 4477 | $10.76 - $10.76 | $48,172 |
| 2024-02-17 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
F | Common Stock | D | 778 | $9.74 - $9.74 | $7,577 |
| 2024-02-17 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
F | Common Stock | D | 4602 | $9.74 - $9.74 | $44,823 |
| 2024-02-17 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
F | Common Stock | D | 1046 | $9.74 - $9.74 | $10,188 |
| 2024-02-17 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
F | Common Stock | D | 1046 | $9.74 - $9.74 | $10,188 |
| 2024-02-09 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
F | Common Stock | D | 3568 | $8.45 - $8.45 | $30,149 |
| 2024-02-09 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
F | Common Stock | D | 3568 | $8.45 - $8.45 | $30,149 |
| 2024-02-09 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
F | Common Stock | D | 3568 | $8.45 - $8.45 | $30,149 |
| 2024-02-09 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
F | Common Stock | D | 12670 | $8.45 - $8.45 | $107,061 |
| 2024-02-05 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
F | Common Stock | D | 1190 | $9.80 - $9.80 | $11,662 |
| 2024-02-01 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
A | Common Stock | A | 48750 | $0.00 - $0.00 | $0 |
| 2024-02-05 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
F | Common Stock | D | 1190 | $9.80 - $9.80 | $11,662 |
| 2024-02-01 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
A | Common Stock | A | 48750 | $0.00 - $0.00 | $0 |
| 2024-02-05 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
F | Common Stock | D | 5068 | $9.80 - $9.80 | $49,666 |
| 2024-02-01 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-02-05 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
F | Common Stock | D | 892 | $9.80 - $9.80 | $8,741 |
| 2024-02-01 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
A | Common Stock | A | 48750 | $0.00 - $0.00 | $0 |
| 2024-01-05 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
F | Common Stock | D | 9671 | $11.53 - $11.53 | $111,506 |
| 2024-01-05 | 89bio, Inc. | Mansbach Harry H
(Chief Medical Officer) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
F | Common Stock | D | 6124 | $11.53 - $11.53 | $70,609 |
| 2024-01-05 | 89bio, Inc. | Martins Ryan
(Chief Financial Officer) |
A | Common Stock | A | 15000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
F | Common Stock | D | 9671 | $11.53 - $11.53 | $111,506 |
| 2024-01-05 | 89bio, Inc. | Le-Nguyen Quoc
(See Remarks) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
F | Common Stock | D | 27511 | $11.53 - $11.53 | $317,201 |
| 2024-01-05 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2023-12-29 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
S | Common Stock | D | 50000 | $11.20 - $11.20 | $560,000 |
| 2023-12-29 | 89bio, Inc. | PALEKAR ROHAN
(Chief Executive Officer) |
M | Common Stock | A | 50000 | $1.93 - $1.93 | $96,500 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |